Fig. 3. Concentration-response curve of propofol-mediated inhibition of sevoflurane protection. (A ) Left ventricular work (LVW). (B ) Diastolic [Ca2+]i. (C ) Representative [Ca2+]itraces of 1-s duration. INDO, Ca2+indicator indo-1 AM; IR, ischemia–reperfusion alone; SEVO+IR, periischemic sevoflurane treatment (2 vol.-%); SEVO/P0.1+IR, periischemic sevoflurane (2 vol.-%) plus propofol (0.1 μM) treatment; SEVO/P1+IR, periischemic sevoflurane (2 vol.-%) plus propofol (1 μM) treatment; SEVO/P10+IR, periischemic sevoflurane (2 vol.-%) plus propofol (10 μM) treatment; SEVO/P100+IR, periischemic sevoflurane (2 vol.-%) plus propofol (100 μM) treatment. *P < 0.05 compared with IR. Data are mean ± SD (A ) and median (25th, 75th percentile) (B ).

Fig. 3. Concentration-response curve of propofol-mediated inhibition of sevoflurane protection. (A ) Left ventricular work (LVW). (B ) Diastolic [Ca2+]i. (C ) Representative [Ca2+]itraces of 1-s duration. INDO, Ca2+indicator indo-1 AM; IR, ischemia–reperfusion alone; SEVO+IR, periischemic sevoflurane treatment (2 vol.-%); SEVO/P0.1+IR, periischemic sevoflurane (2 vol.-%) plus propofol (0.1 μM) treatment; SEVO/P1+IR, periischemic sevoflurane (2 vol.-%) plus propofol (1 μM) treatment; SEVO/P10+IR, periischemic sevoflurane (2 vol.-%) plus propofol (10 μM) treatment; SEVO/P100+IR, periischemic sevoflurane (2 vol.-%) plus propofol (100 μM) treatment. *P < 0.05 compared with IR. Data are mean ± SD (A ) and median (25th, 75th percentile) (B ).

Close Modal

or Create an Account

Close Modal
Close Modal